SR 851: Georgia Senate; creation of a life sciences caucus; encourage
Last action February 25, 2026 · Senate Read and Referred
A Georgia Senate resolution encourages senators to form a life sciences caucus, a bipartisan group meant to focus on biotechnology, pharmaceuticals, and related industries in the state.
The summaries below were written by an AI model (claude-sonnet-5) from the text of the resolution and are not part of it. Quote the text, not the summary. The stored text is the Introduced version, the latest LegiScan holds.
In plain language
This resolution does not create a new law or spend state money. It is a formal statement from the Georgia Senate encouraging its members to set up a life sciences caucus, an informal group of senators who would meet to learn about and discuss the life sciences sector, which includes biotechnology, pharmaceuticals, medical devices, diagnostics, and agricultural biotechnology. The resolution explains why senators think this matters: Georgia has research universities, medical centers, and manufacturers tied to life sciences, and the sector supports jobs and public health. It says a caucus would give lawmakers a bipartisan forum to learn from industry leaders, academic institutions, and patient groups through briefings and site visits. The only binding instructions are procedural: the Senate resolves to encourage the caucus's creation, and it directs the Secretary of the Senate to distribute copies of the resolution to the public and press.
What the bill does
- Formally encourages Georgia senators to establish a life sciences caucus within the Senate.
- Describes the caucus as a bipartisan forum for legislators to learn about biotechnology, pharmaceuticals, medical devices, and agricultural biotechnology.
- Directs the Secretary of the Senate to distribute copies of the resolution to the public and press.
- Does not create any new agency, program, funding, or legal requirement; it only expresses the Senate's encouragement.
Who it affects
Georgia state senators, who would be encouraged to join or form the caucus, and by extension life sciences companies, research universities, academic medical centers, and workforce partners the caucus might engage with through briefings and site visits.
Why it matters
If senators act on this encouragement, it could lead to a standing group focused on life sciences policy, giving industry and academic stakeholders a more direct line to lawmakers. On its own, though, the resolution changes no law, funding, or rules.
Key provisions
- The whereas clauses lay out the Senate's reasoning, citing the life sciences sector's role in Georgia's economy, workforce, and public health.
- The resolving clause states the Senate encourages creation of a life sciences caucus in the Georgia Senate.
- A further resolving clause directs the Secretary of the Senate to make copies available to the public and press.
From the bill
“NOW, THEREFORE, BE IT RESOLVED BY THE SENATE that the members of this body encourage the creation of a life sciences caucus in the Georgia Senate.”
Status timeline
- Senate Read and Referred (Senate)
- Senate Hopper (Senate)
Sponsors
- Chuck Hufstetler (R, SD-052)
- Ben Watson (R, SD-001)
- Drew Echols (R, SD-049)
- Shawn Still (R, SD-048)
- Carden Summers (R, SD-013)
- Kenya Wicks (D, SD-034)
- Frank Ginn (R, SD-047)
- Michael Rhett (D, SD-033)
Topics
- life sciences
- biotechnology
- economic development
- legislative caucus
- healthcare policy